HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei-Wen Kuo Selected Research

Neoplasm Metastasis (Metastasis)

1/2018Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis.
8/2017Taiwanin E inhibits cell migration in human LoVo colon cancer cells by suppressing MMP-2/9 expression via p38 MAPK pathway.
4/2017Lactate dehydrogenase downregulation mediates the inhibitory effect of diallyl trisulfide on proliferation, metastasis, and invasion in triple-negative breast cancer.
2/2017Inhibition of NF-κB and metastasis in irinotecan (CPT-11)-resistant LoVo colon cancer cells by thymoquinone via JNK and p38.
11/2014Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
7/2014Resistance to irinotecan (CPT-11) activates epidermal growth factor receptor/nuclear factor kappa B and increases cellular metastasis and autophagy in LoVo colon cancer cells.
8/2011JNK suppression is essential for 17β-Estradiol inhibits prostaglandin E2-Induced uPA and MMP-9 expressions and cell migration in human LoVo colon cancer cells.
8/2011β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
9/2006Over-expressed estrogen receptor-alpha up-regulates hTNF-alpha gene expression and down-regulates beta-catenin signaling activity to induce the apoptosis and inhibit proliferation of LoVo colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei-Wen Kuo Research Topics

Disease

41Cardiomegaly (Heart Hypertrophy)
01/2024 - 11/2004
40Neoplasms (Cancer)
12/2023 - 07/2006
40Hypertrophy
02/2022 - 11/2004
31Fibrosis (Cirrhosis)
03/2024 - 10/2005
25Inflammation (Inflammations)
05/2024 - 05/2006
23Hypoxia (Hypoxemia)
01/2023 - 03/2007
19Hypertension (High Blood Pressure)
12/2022 - 01/2004
16Heart Failure
01/2024 - 05/2006
14Cardiomyopathies (Cardiomyopathy)
03/2024 - 10/2010
12Diabetic Cardiomyopathies
03/2024 - 01/2011
11Heart Diseases (Heart Disease)
11/2023 - 10/2005
11Hyperglycemia
03/2023 - 04/2012
11Colonic Neoplasms (Colon Cancer)
01/2023 - 04/2006
11Hepatocellular Carcinoma (Hepatoma)
01/2022 - 10/2006
10Cardiotoxicity
12/2023 - 09/2016
10Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 10/2009
9Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 04/2006
9Mitochondrial Diseases (Mitochondrial Disease)
12/2023 - 02/2015
9Neoplasm Metastasis (Metastasis)
01/2018 - 09/2006
8Wounds and Injuries (Trauma)
12/2023 - 01/2016
7Body Weight (Weight, Body)
09/2021 - 02/2003
6Lung Neoplasms (Lung Cancer)
12/2023 - 01/2021
6Myocardial Infarction
06/2019 - 05/2008
6Obesity
01/2019 - 10/2007
5Necrosis
03/2023 - 03/2007
5Parkinson Disease (Parkinson's Disease)
01/2023 - 11/2010
4Melanoma (Melanoma, Malignant)
05/2024 - 12/2019
4Hemorrhagic Shock
12/2023 - 06/2015
4Diabetes Mellitus
01/2021 - 09/2015
4Carcinogenesis
12/2019 - 11/2014
4Hyperlipidemias (Hyperlipidemia)
01/2019 - 01/2016
3Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
12/2023 - 05/2009
3Rheumatoid Arthritis
10/2022 - 05/2006

Drug/Important Bio-Agent (IBA)

51Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2005
16Angiotensin IIIBA
12/2022 - 07/2006
14CalcineurinIBA
02/2022 - 12/2005
14Insulin-Like Growth Factor II (Somatomedin A)IBA
12/2021 - 07/2006
13Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024 - 04/2012
12Estrogen ReceptorsIBA
09/2023 - 07/2006
11Doxorubicin (Adriamycin)FDA LinkGeneric
12/2023 - 09/2016
11Insulin-Like Growth Factor I (IGF-1)IBA
11/2023 - 09/2005
11Atrial Natriuretic Factor (ANF)IBA
10/2019 - 11/2004
10Insulin-Like PeptidesIBA
12/2023 - 05/2006
10IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA
09/2023 - 07/2006
10CollagenIBA
11/2022 - 01/2011
9Matrix Metalloproteinases (MMPs)IBA
11/2023 - 05/2006
8Estrogens (Estrogen)FDA Link
01/2023 - 09/2006
8Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2022 - 05/2008
8Glucose (Dextrose)FDA LinkGeneric
10/2021 - 09/2013
8Streptozocin (Streptozotocin)FDA Link
09/2021 - 10/2010
7Phosphotransferases (Kinase)IBA
12/2021 - 05/2009
6Sirtuin 1IBA
12/2023 - 01/2018
6Transcription Factors (Transcription Factor)IBA
11/2022 - 06/2008
5Therapeutic UsesIBA
03/2024 - 02/2013
5TeaIBA
03/2024 - 03/2014
5MicroRNAs (MicroRNA)IBA
12/2023 - 01/2018
5AntioxidantsIBA
12/2023 - 09/2013
5GemcitabineFDA Link
12/2023 - 01/2021
5LipidsIBA
01/2023 - 04/2006
5Advanced Glycation End ProductsIBA
08/2022 - 08/2018
5Mitogen-Activated Protein KinasesIBA
02/2022 - 04/2005
5Hematoxylin (Haematoxylon)IBA
01/2022 - 10/2007
5Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 10/2007
5CateninsIBA
09/2019 - 08/2011
5Brain Natriuretic Peptide (Natrecor)FDA Link
01/2019 - 05/2008
4epigallocatechin gallate (epigallocatechin-3-gallate)IBA
03/2024 - 11/2017
4Irinotecan (Camptosar)FDA LinkGeneric
12/2023 - 07/2014
4Growth Hormone (Somatotropin)IBA
11/2023 - 05/2006
4Phytoestrogens (Phytoestrogen)IBA
09/2023 - 09/2016
4CytokinesIBA
08/2023 - 05/2009
4Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2023 - 01/2018
4Protein Kinases (Protein Kinase)IBA
02/2022 - 04/2005
4Histone Deacetylase InhibitorsIBA
01/2022 - 01/2014
4diallyl trisulfideIBA
10/2021 - 02/2013
4Insulin-Like Growth Factor Binding Protein 3IBA
10/2021 - 01/2015
4Protein Phosphatase 1IBA
11/2020 - 04/2017
4Galactose (Galactopyranose)FDA LinkGeneric
01/2020 - 03/2016
4transcription factor NF-AT c3IBA
11/2019 - 01/2015
4Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2019 - 05/2009
4Plasminogen Activators (Plasminogen Activator)IBA
06/2019 - 05/2009
4CholesterolIBA
11/2017 - 09/2009
4Apoptosis Regulatory ProteinsIBA
01/2017 - 04/2008
4Tobacco Smoke Pollution (Passive Smoking)IBA
09/2016 - 10/2005
4Transforming Growth Factor beta (TGF-beta)IBA
05/2016 - 11/2004
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 03/2007
4Death Domain ReceptorsIBA
09/2009 - 10/2005
3FlavonoidsIBA
12/2023 - 06/2019
3Biomarkers (Surrogate Marker)IBA
11/2023 - 02/2009
3fisetinIBA
09/2023 - 06/2019
37,3'-dihydroxy-4'-methoxyisoflavoneIBA
07/2023 - 04/2022
3Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
01/2023 - 01/2019
3ParaquatIBA
01/2023 - 07/2019
3Fatty Acids (Saturated Fatty Acids)IBA
01/2023 - 01/2016
3LipopolysaccharidesIBA
01/2023 - 06/2008
3InterleukinsIBA
11/2022 - 05/2006
3Arecoline (Arecolin)IBA
02/2022 - 04/2013

Therapy/Procedure

22Therapeutics
12/2023 - 04/2006
9Drug Therapy (Chemotherapy)
12/2023 - 07/2014
6Oral Administration
07/2021 - 06/2013
4Transplantation
01/2022 - 11/2017